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Exposures constitute a dense network of the environment: exposome. Here, we argue for embracing 
the exposome paradigm to investigate the sum of nongenetic “risk” and show how predictive modeling 
approaches can be used to construct an exposome score (ES; an aggregated score of exposures) for 
schizophrenia. The training dataset consisted of patients with schizophrenia and controls, whereas the 
independent validation dataset consisted of patients, their unaffected siblings, and controls. Binary 
exposures were cannabis use, hearing impairment, winter birth, bullying, and emotional, physical, 
and sexual abuse along with physical and emotional neglect. We applied logistic regression (LR), 
Gaussian Naive Bayes (GNB), the least absolute shrinkage and selection operator (LASSO), and Ridge 
penalized classification models to the training dataset. ESs, the sum of weighted exposures based on 
coefficients from each model, were calculated in the validation dataset. In addition, we estimated ES 
based on meta-analyses and a simple sum score of exposures. Accuracy, sensitivity, specificity, area 
under the receiver operating characteristic, and Nagelkerke’s R2 were compared. The ESMeta-analyses 
performed the worst, whereas the sum score and the ESGNB were worse than the ESLR that performed 
similar to the ESLASSO and ESRIDGE. The ESLR distinguished patients from controls (odds ratio [OR] = 
1.94, P < .001), patients from siblings (OR = 1.58, P < .001), and siblings from controls (OR = 1.21, P 
= .001). An increase in ESLR was associated with a gradient increase of schizophrenia risk. In reference 
to the remaining fractions, the ESLR at top 30%, 20%, and 10% of the control distribution yielded ORs 
of 3.72, 3.74, and 4.77, respectively. Our findings demonstrate that predictive modeling approaches 
can be harnessed to evaluate the exposome. 
 
Key words: schizophrenia/psychosis/predictive modeling/ machine learning/risk 
score/environment/childhood trauma/cannabis/winter birth/hearing impairment 
 
Introduction 
Several environmental exposures have been associated with psychosis spectrum disorder.1,2 Knowledge on 
this association has thus far been deduced from hypothesis driven selective one-exposure to one-outcome 
studies, akin to the candidate-gene approach.3 However, each exposure constitutes a fraction of a dense 
network of exposures: the exposome.4 Here, we argue for embracing the exposome paradigm to investigate 
the sum of the nongenetic “risk” and show how a predictive modelling approach can be used to construct an 
exposome score (ES) for schizophrenia, a single metric of aggregated environmental load similar to 
polygenic risk score.5 
 
Approach 
Guided by the predictive modeling methods for constructing cumulative environmental exposure scores,6,7 
we used 2 independent datasets to, first, build a predictive model in the training dataset (the Work-package 
6 of the European Network of National Networks studying Gene-Environment Interactions in Schizophrenia 
[EUGEI]2) and, second, construct and test the ES in the validation dataset (the Genetic Risk and Outcome of 
Psychosis [GROUP] study8). We examined the following widely evaluated environmental factors that we 
also recently investigated individually within the context of gene-environment interaction9: hearing 
impairment, winter birth, cannabis use, and childhood adversities (bullying, emotional, physical, and sexual 
abuse along with emotional and physical neglect).10 Our analysis was limited to the environmental exposures 
that were reliably measured and equally available in both datasets. These environmental factors were defined 
according to previous studies.9 The detailed description of each environmental exposure is provided in the 
supplementary file. We used 4 prediction models to determine to what degree cumulative environmental 
exposure contributes to the liability for schizophrenia in a case-control design. Logistic regression (LR), 
Gaussian Naive Bayes (GNB), and penalized logistic regression (least absolute shrinkage and selection 
operator [LASSO] and Ridge) were applied to data with complete information on environmental exposures. 
The description of the models and the distribution of exposures are provided in the supplementary file. For 
each model, the dependent variable was the binary case-control status, whereas binary environmental 
exposures were features (independent variables). First, we estimated coefficients of binary exposures in the 
training dataset including 1241 healthy controls and 747 patients with a diagnosis of schizophrenia spectrum 
disorders. Second, we calculated the weighted sum of the exposures according to each predictive model in 
an independent validation dataset with 323 healthy controls, 463 patients with a diagnosis of schizophrenia 
spectrum disorders, and 542 unaffected siblings of the patients. To compare the performance of ES from 
each model, we also generated an environmental sum score by simply adding each binary exposure per 
individual as 0 = absent and 1 = present (the sum score is ranging from 0 to 9) and a cumulative 
environmental score weighted by the metanalytical estimates for each exposure,11–14 conforming to a previous 
study.15 Finally, we tested the performance of ESs derived from each model by applying logistic regression 
in a case-control design in the independent validation dataset by evaluating the area under the receiver 
operating characteristic (ROC), accuracy (ACC), sensitivity, specificity, and Nagelkerke’s pseudo R2. In this 
regard, we prioritized models with better sensitivity than specificity as our main concern was to avoid 
misclassifying individuals diagnosed with schizophrenia. 
 
Prediction in the Training Dataset 
The coefficients of individual models (see figure 1a and supplementary table S2) indicate that cannabis use 
(coefficients ranging from 1.31 to 1.53), hearing impairment (coefficients: 1.10–1.19), and bullying 
(coefficients: 1.30–1.57) received the highest weights in the training dataset. The lowest weight was 
attributed to winter birth with coefficients between 0.01 and 0.06. In comparison with the GNB model, which 
assumes independence between predictors, the LR, Ridge, and LASSO models yielded lower weights for 
emotional abuse, sexual abuse, emotional neglect, physical neglect, and bullying. Further, although physical 
abuse was a strong positive predictor in the GNB model, its predictive value was lost and even yielded a 
negative weight when using predictive model approaches that account for dependence between the 
predictors. This is in line with evidence that exposures are weakly to moderately correlated with each 
other.3,16–18 Consequently, coefficients are overestimated when independence is assumed. 
 
 
Fig. 1. (a) Coefficients profile for each exposure derived from different classification methods in the training dataset, GNB: 
Gaussian Naive Bayes, LR: logistic regression. (b) The area under the receiver operating characteristic for the different 
exposome scores in the validation dataset. (c) The histogram of the ESLR (exposome score based on logistic regression) for 
patients, siblings, and controls in the validation dataset. For visualization, a Gaussian distribution was fit to histogram counts 
by adjusting mean and standard deviations. (d) The risk strata plot of the ESLR on case-control status: The ESLR was divided 
into 5 quintiles (X-axis) of the control distribution and logistic regression was applied to case-control status as the dependent 
variable. The third quintile includes the median and was used as reference. The Y-axis represents odds ratios and the error bars 
show confidence intervals. 
 
Constructing and Testing the Performance of Exposome Score in an Independent Dataset 
The ROC was used to estimate the performance of the calculated ESs in predicting the case-control status in 
the validation dataset (figure 1b and supplementary table S3). The ES based on meta-analytical estimates 
(the ESMeta-analyses), ESGNB, and the environmental sum score yielded the lowest ROC, 0.69, 0.71, and 0.71, 
respectively, whereas all other ESs (ESLR, ESRIDGE, and ESLASSO) had ROC ranging from 0.73 to 0.74. With a 
chance level of 0.5 (as patients and controls were in balance in the training sample; see supplementary file), 
all ESs indicated an ACC above chance level (ACC: 0.62–0.68) with specificity between 0.42 and 0.72 and 
sensitivity between 0.56 and 0.86. Compared to the ESLR, ESRIDGE, and ESLASSO, the ESs derived from the 
models assuming independence between exposures (ESGNB, environmental sum score, and ESMeta-analyses) 
performed worse on sensitivity and had more false negatives as they incorrectly classified patients as healthy. 
Given that our priority was reducing false negatives rather than reducing false positives and that the ESLR, 
ESRIDGE, and ESLASSO performed similarly well (figure 1b and supplementary table S3), we reported further 
analyses with the ESLR, which was constructed on the basis of a widely available and commonly used 
statistical model, logistic regression. 
 
To examine whether the ESLR reflects schizophrenia liability in the validation dataset, we evaluated the ESLR 
in patients, siblings, and controls (see figure 1c for an illustration and supplementary table S4 for the other 
models). The ESLR discriminated patients from controls (odds ratio [OR] = 1.94; 95% confidence interval 
[CI] = 1.71–2.20; P < .001, Nagelkerke’s pseudo R2 = 0.21), also after adjusting for age and sex (OR = 1.87; 
95% CI = 1.64–2.14; P < .001) in the validation dataset. Similarly, logistic regression 
analysis showed higher ESLR in patients compared to siblings (OR = 1.58; 95% CI = 1.43–1.74; P < .001; 
adjusted for age and sex: OR = 1.55; 95% CI = 1.40–1.72; P < .001) and in siblings compared to controls 
(OR = 1.21; 95% CI = 1.08–1.36; P = .001; adjusted for age and sex: OR = 1.23; 95% CI = 1.09–1.38; P < 
.001). 
To visually represent the risk stratification properties of the ESLR, we categorized the ESLR using the quintiles 
of the control distribution and measured the case-control ORs using the middle quintile (median ESLR) as the 
reference. With an increase of the ESLR, we noticed a gradient increase in the risk for schizophrenia. In 
comparison with the median, the fifth quintile had a higher OR (OR = 3.47; 95% CI = 2.22–5.41; P < .001 
and age- and sex-adjusted OR = 3.78; 95% CI = 2.34–6.09; P < .001) and the first quintile had a lower OR 
(OR = 0.30; 95% CI = 0.17–0.53; P < .001 and age- and sex-adjusted OR = 0.34; 95% CI = 0.19–0.62; P < 
.001; figure 1c). We then dichotomized the ESLR with cut off points at 70%, 80%, and 90% of the control 
distribution. Comparing the top and the bottom part translated to ORs of 3.81, 3.96, and 5.11 (age- and sex-
adjusted ORs of 3.72, 3.74, and 4.77) for 70%, 80%, and 90% of the distribution, respectively 
(supplementary table S5). 
 
Discussion 
For the first time, we applied a predictive modelling approach to construct the ES for schizophrenia by 
leveraging 2 large independent datasets (training and validation data) with similar assessment protocols for 
environmental exposures. Our findings suggest that predictive modeling can be used to estimate 
environmental loading of a range of exposures. We found that the ESLR, ESRIDGE, and ESLASSO performed 
similarly well, whereas the ESs derived from the models assuming independence performed worse. Of the 
ESGNB, ESMeta-analyses, and the simple summation of exposures, the ESMeta-analyses, relying on the external sources 
for extracting estimates for environmental exposures, showed the worst performance. The low performance 
of the ES driven by meta-analyses might be related to the fact that meta-analytical estimates are derived from 
different studies that use different assessments, different definitions, and different cutoff points for exposures 
in different study populations,3 which might not be completely compatible with the dataset at hand. The 
availability of similar training and validation datasets plays a major role in prediction power—for instance, 
the predictive performance of polygenic scores for schizophrenia is considerably lower in non-Caucasian 
ancestry samples.19 Therefore, a similar situation exists in estimating genetic liability, which, however, has 
the advantage of using more concrete, uniformly measured genetic variation for prediction in comparison to 
environmental assessment. Generating a uniform “environmental risk score” is even more challenging. For 
instance, cannabis use could be scored positive if participants smoke daily, or at least weekly, or at least 
monthly for lifetime use or exposure during adolescence, whereas childhood adversities could similarly be 
measured by various methods. Therefore, as weights are determined by how strict or lenient the cutoff points 
are, it is likely that the inconsistency between sampling and measurement strategies would introduce bias. 
Further, when individual coefficients from meta-analyses are used for a weighted environmental score, 
correlations between exposures are ignored, and weights may be overestimated.3 In line with this, we also 
show that GNB, which assumes independence between predictors, produces higher weights for exposures 
than the other data-driven models.  
Similar to current results, previous studies show that more contemporary algorithms do not necessarily 
translate into superior performance over logistic regression for clinical prediction modeling.20,21 However, it 
should be noted that our analysis did not involve a complex data structure with many predictors. Penalized 
classification models might have led to performance improvement if more complex structures had to be 
considered (eg, increasing the number of predictors and adding pairwise interactions). Researchers likewise 
need to be cautious about overfitting models and be aware that, if environmental exposures are correlated, 
the initial simple model with a few predictors will show the highest portion of improvement. However, each 
sequentially added predictor would result in less and less improvement in model performance.21 
The ESs assuming independence between predictors (sum score, ESMeta-analyses, and ESGNB) had lower 
sensitivity than the rest. The ESMeta-analyses indicated the lowest sensitivity (56%). The sensitivity of an 
environmental score derived from meta-analytical estimates in a previous study was even lower, only around 
7%–9%.15 In other words, predictive models that do not assume independence between exposures may more 
accurately classify patients as positive by decreasing false negatives. The ESs from the models assuming 
independence, however, had higher specificity and were better in decreasing false positives. As our main 
concern was to avoid misclassifying individuals diagnosed with schizophrenia, we chose sensitivity over 
specificity. Further, if more environmental exposures were to be included in the ES, thus introducing more 
correlation, the models not assuming independence between predictors (ESLR, ESRIDGE, and ESLASSO) would 
perform increasingly better than the models assuming independence 
(sum score, ESMeta-analyses, and ESGNB). 
The ESLR, generated using an easily accessible method (logistic regression), achieved similar performance 
results compared with the ESRIDGE and ESLASSO. We used the ESLR to further explore the characteristics of the 
ES in the follow- up analyses. In general, patients had higher ESLR than both controls and siblings, whereas 
siblings had higher ESLR than controls. The ESLR explained more variance (Nagelkerke R2 = 0.21) than the 
ESMeta-analyses (Nagelkerke R2 = 0.13). In accordance with our previous findings showing an additive effect for 
environmental factors,22,23 our results indicate that the ESLR shows a dose-response effect: the odds of 
schizophrenia increase as a function of the ESLR. Eventually, an individual with ESLR in the top 10% of the 
control distribution was around 5 times more likely to have schizophrenia compared to an individual below 
that cutoff. 
 
Limitations of Exposome Score 
Our analysis was limited to the environmental exposures that were reliably measurable and equally available 
in both datasets. The ES can be extended to include other environmental exposures (eg, obstetric and 
pregnancy complications and urban environment). We included winter birth as an exposure in the current 
analyses as previous studies suggest an association between winter birth and psychosis.14 However, summer 
birth was also previously associated with deficit schizophrenia and might therefore be evaluated as an 
exposure as well.24,25 Considering evidence showing that common environmental factors (eg, childhood 
adversity) are not specific to the psychosis phenotype but instead are more generally related to 
psychopathology,26,27 the ES would likely (to a degree) be associated with other mental disorders in mixed 
samples. Therefore, a low discriminant capacity for the ES should be anticipated. Given the nature of 
observational studies, causality claims should be avoided. Finally, it should be noted that although 
aggregating exposures leads to an increase in the predictive power and may be particularly beneficial in 
exploring shared mechanisms, the inherent heterogeneity of a single score may lead to information loss and 
biological imprecision. Considering the reasons described earlier, we have avoided using the term “risk” and 
opted for a neutral alternative: ES. 
 
Conclusion 
Our findings demonstrate that predictive modelling approaches can be harnessed to evaluate the exposome. 
In the future, we aim to explore models by including more exposures as well as interaction terms and test 
the predictive power of the ES in epidemiologically representative general population cohorts. 
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